AnalystsCharles ZhuCharles Zhu's Stock Forecasts
AnalystsCharles Zhu
Sectors:
Industries:
Analyst Ranking
Top 19%
#872 out of 4577 analysts
Average Return
+35.01%
Win Rate
57%8 out of 14
Risk vs Reward
Poor
Good
Charles Zhu's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ideaya Biosciences IncIDYA | +162.81% | $17.21 | $45.23 | 2023-03-07 - 2024-03-07 | Strong Buy |
Macrogenics IncMGNX | +151.96% | $6.37 | $16.05 | 2023-11-06 - 2024-05-07 | Strong Buy |
Ideaya Biosciences IncIDYA | +134.58% | $12.52 | $29.37 | 2022-09-12 - 2023-09-12 | Strong Buy |
Merus NvMRUS | +112.24% | $22.96 | $48.73 | 2023-08-07 - 2024-05-07 | Strong Buy |
Merus NvMRUS | +68.38% | $23.94 | $40.31 | 2023-04-16 - 2024-04-16 | Strong Buy |
Charles Zhu Analyst Color
Get additional color on Charles Zhu's coverage of popular stocks
Charles Zhu's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Macrogenics IncMGNX | 2 | Strong Buy | $12.00 | -25.23% | Upgrades | 6 months ago |
Merus NvMRUS | 3 | Strong Buy | $48.00 | -1.50% | Maintains | 9 months ago |
Nuvalent IncNUVL | 1 | Strong Buy | $56.00 | -18.41% | Initiates Coverage On | 9 months ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $22.00 | +666.55% | Assumes | 10 months ago |
Cogent Biosciences IncCOGT | 3 | Strong Buy | $26.00 | +235.05% | Reiterates | a year ago |
Ideaya Biosciences IncIDYA | 2 | Strong Buy | $32.00 | N/A | Reiterates | a year ago |
Point Biopharma Global IncPNT | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Tango Therapeutics IncTNGX | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.